Emergent BioSolutions Sees FY24 Revenue $900M-$1.10B Vs $ $1.184B Est.
Portfolio Pulse from Benzinga Newsdesk
Emergent BioSolutions projects its FY24 revenue to be between $900 million and $1.10 billion, which is below the estimated $1.184 billion.
March 06, 2024 | 9:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Emergent BioSolutions projects lower-than-expected FY24 revenue, estimating between $900 million and $1.10 billion versus an estimate of $1.184 billion.
The projected revenue for FY24 by Emergent BioSolutions is significantly lower than the market's expectation. This discrepancy is likely to negatively impact investor sentiment and could lead to a decrease in the stock price in the short term, as investors adjust their expectations based on the new guidance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100